Detalhe da pesquisa
1.
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.
Blood
; 130(5): 597-605, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550039
2.
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
Invest New Drugs
; 35(5): 634-641, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28527133
3.
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis.
Br J Haematol
; 174(5): 748-59, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196567
4.
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment.
Br J Clin Pharmacol
; 82(3): 728-38, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121262
5.
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.
Int J Geriatr Psychiatry
; 26(6): 564-72, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20827794
6.
Evolution of enzymatic activities of testis-specific short-chain dehydrogenase/reductase in Drosophila.
J Mol Evol
; 71(4): 241-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20809353
7.
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies.
J Clin Psychopharmacol
; 29(4): 362-7, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19593176
8.
Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor.
Clin Pharmacol Ther
; 105(2): 376-387, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446068
9.
Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.
Inflamm Bowel Dis
; 25(4): 803-810, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295811
10.
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.
Eur J Cancer
; 106: 89-98, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30471652
11.
Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.
Prim Care Companion J Clin Psychiatry
; 10(6): 440-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19287552
12.
TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study.
Cancer Res Treat
; 50(2): 398-404, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28494535
13.
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.
Target Oncol
; 12(5): 643-654, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28803351
14.
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.
J Crohns Colitis
; 11(8): 921-929, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333288
15.
Statistical criteria for the identification of protein active sites using Theoretical Microscopic Titration Curves.
Proteins
; 59(2): 183-95, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15739204
16.
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study.
J Hematol Oncol
; 8: 103, 2015 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26337806
17.
Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.
J Crohns Colitis
; 12(4): 510, 2018 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385425
18.
High-performance prediction of functional residues in proteins with machine learning and computed input features.
Biopolymers
; 95(6): 390-400, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21254002
19.
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
J Clin Psychiatry
; 69(12): 1928-36, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19192475
20.
Future directions in protein function prediction.
Mol Biol Rep
; 29(4): 329-35, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12549818